Suven Pharmaceuticals Limited (SUVENPHAR.NS)

666.00 -2.40 (-0.36%) At close: 03:29PM IST

Suven Pharmaceuticals Limited

Galaxy Towers
202, A-Wing Plot No.1, Hyderabad Knowledge City TSIIC, Raidurg
Hyderabad 500081
India
91 40 2354 9414
https://www.suvenpharm.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Vaidheesh Annaswamy	Executive Chairman	N/A	N/A	N/A
Dr. Sudhir Kumar Singh Ph.D.	Chief Executive Officer	N/A	N/A	1965
Mr. Himanshu Agarwal	Chief Financial Officer	N/A	N/A	1970
Dr. K. Nagendra Babu	Chief Quality & Compliance Officer	N/A	N/A	N/A
Mr. Gaurav Narain Bahadur	Chief Human Resources Officer	N/A	N/A	1970
Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju	MD & Director	N/A	N/A	N/A
Mr. Subba Raju Komaravolu	Chief Strategy Officer	N/A	N/A	N/A
Mr. Brian Shaughnessy	Chief Commercial Officer	N/A	N/A	N/A
Mr. K. Hanumantha Rao	Company Secretary	N/A	N/A	1963
Mr. Sunder Venkatraman	Vice President of Corporate Affairs	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. As of September 29, 2023, Suven Pharmaceuticals Limited operates as a subsidiary of Berhyanda Limited.

Corporate governance

Suven Pharmaceuticals Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.